InfuSystem (INFU) Competitors $5.70 +0.10 (+1.79%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$5.70 0.00 (0.00%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INFU vs. BFLY, DCTH, TMCI, OM, SNWV, RXST, CLPT, CATX, NNOX, and STIMShould you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include Butterfly Network (BFLY), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. InfuSystem vs. Its Competitors Butterfly Network Delcath Systems Treace Medical Concepts Outset Medical Sanuwave Health RxSight ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Neuronetics InfuSystem (NYSE:INFU) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability. Do analysts rate INFU or BFLY? InfuSystem presently has a consensus target price of $12.50, suggesting a potential upside of 119.30%. Butterfly Network has a consensus target price of $3.50, suggesting a potential upside of 148.23%. Given Butterfly Network's higher probable upside, analysts plainly believe Butterfly Network is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00Butterfly Network 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media favor INFU or BFLY? In the previous week, Butterfly Network had 10 more articles in the media than InfuSystem. MarketBeat recorded 12 mentions for Butterfly Network and 2 mentions for InfuSystem. InfuSystem's average media sentiment score of 0.61 beat Butterfly Network's score of 0.54 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in INFU or BFLY? 71.1% of InfuSystem shares are held by institutional investors. Comparatively, 37.9% of Butterfly Network shares are held by institutional investors. 11.4% of InfuSystem shares are held by company insiders. Comparatively, 25.2% of Butterfly Network shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, INFU or BFLY? InfuSystem has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.45, indicating that its share price is 145% more volatile than the S&P 500. Which has better earnings & valuation, INFU or BFLY? InfuSystem has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$137.58M0.87$870K$0.1440.71Butterfly Network$82.06M4.25-$72.49M-$0.29-4.86 Is INFU or BFLY more profitable? InfuSystem has a net margin of 1.12% compared to Butterfly Network's net margin of -75.56%. InfuSystem's return on equity of 2.78% beat Butterfly Network's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Butterfly Network -75.56%-29.97%-21.13% SummaryInfuSystem beats Butterfly Network on 11 of the 17 factors compared between the two stocks. Get InfuSystem News Delivered to You Automatically Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INFU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INFU vs. The Competition Export to ExcelMetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$119.79M$65.17M$5.47B$20.63BDividend YieldN/AN/A4.73%3.67%P/E Ratio95.026.2128.8929.01Price / Sales0.87109.49371.4465.92Price / Cash12.7918.4135.4522.82Price / Book2.316.678.264.43Net Income$870K-$25.86M$3.25B$993.74M7 Day Performance-5.16%-7.76%-3.73%-3.39%1 Month Performance-7.62%1.49%4.28%-2.10%1 Year PerformanceN/A44.06%25.85%10.09% InfuSystem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INFUInfuSystem3.0065 of 5 stars$5.70+1.8%$12.50+119.3%N/A$119.79M$137.58M95.02410BFLYButterfly Network2.4271 of 5 stars$1.93-2.0%$3.50+81.3%+36.9%$487.16M$82.06M-6.66460Trending NewsAnalyst DowngradeGap DownDCTHDelcath Systems2.6982 of 5 stars$11.41flat$24.00+110.3%+29.3%$397.37M$53.85M-22.8260Upcoming EarningsAnalyst UpgradeTMCITreace Medical Concepts2.4138 of 5 stars$5.75+0.9%$10.52+82.9%-19.0%$358.47M$209.36M-6.76250News CoveragePositive NewsUpcoming EarningsOMOutset Medical1.7077 of 5 stars$18.04-2.6%$29.50+63.5%-71.4%$328.39M$115.27M-0.62520Upcoming EarningsSNWVSanuwave Health2.2756 of 5 stars$35.75-5.6%N/AN/A$324.43M$32.63M-7.8540News CoverageAnalyst ForecastAnalyst RevisionRXSTRxSight3.3645 of 5 stars$7.87-1.3%$17.50+122.4%-82.4%$323.88M$139.93M-11.75220Trending NewsUpcoming EarningsCLPTClearPoint Neuro2.6744 of 5 stars$10.97-2.3%$25.00+127.9%+47.1%$307.04M$32.24M-14.43110Analyst ForecastGap DownCATXPerspective Therapeutics2.3993 of 5 stars$4.12+1.5%$12.56+204.7%-72.5%$305.82MN/A0.0070News CoverageNNOXNano-X Imaging2.3637 of 5 stars$5.14-1.2%$9.50+84.8%-41.1%$300.45M$11.55M-5.71190News CoverageGap DownSTIMNeuronetics1.5385 of 5 stars$4.52+0.7%$5.50+21.7%+148.3%$296.85M$74.89M-3.45180Upcoming EarningsGap Down Related Companies and Tools Related Companies BFLY Competitors DCTH Competitors TMCI Competitors OM Competitors SNWV Competitors RXST Competitors CLPT Competitors CATX Competitors NNOX Competitors STIM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INFU) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.